Comera Life Sciences Debuts in the Red

by BA Research | May 20, 2022 | SPACs

The maker of self-injectible biologics closed down 9% on the day. An updated look at deSPAC count and redemption rates. ————————————————-Free Investor Resources from...

Weekly Executive & Director Moves (May 20)

by BA Research | May 20, 2022 | CEO / CFO / Director Resignations & Appointments, Featured

Boardroom Alpha provides in-depth analytics and tracking of all public company executives and officers. Below is a rundown of people moves made at notable companies this past week. Get a demo today to see how you can receive real-time alerts and in-depth analytics....

SPAC Deals on a Daily Double

by BA Research | May 19, 2022 | SPACs

Another 2 SPAC DAs today, offset by some liquidations. And the rest of the day’s news in SPACs. ————————————————-Free Investor Resources from Boardroom...

Target’s Bloodbath

by BA Research | May 18, 2022 | Earnings, ESG

With inflation proving to be a slow-moving illness, governance and execution will be key for retail stocks. Target confirms our worst consumer retail fears. Retailer Target (TGT) reported poor Q1 earnings and guidance, sending the shares down 25% on the day– the...

MSP Recovery Approved Amidst Market Bloodbath

by BA Research | May 18, 2022 | SPACs

LCAP gets approval for MSP Recovery. And the rest of the day’s news in SPACs. ————————————————-Free Investor Resources from Boardroom...